Colgate (CL) CLO exercises options and sells 22,000 common shares

Rhea-AI Filing Summary

Colgate-Palmolive’s Chief Legal Officer and Secretary, Jennifer Daniels, reported an option exercise and share sale. On February 4, 2026, she exercised stock options for 22,000 shares of common stock at $72.29 per share under the company’s incentive plan, increasing her direct holdings to 98,406 shares.

That same day, she sold 22,000 shares of common stock at a weighted average price of $94.3363 per share in multiple transactions, leaving 76,406 shares held directly. A footnote explains that part of the sale proceeds went to Colgate-Palmolive to cover the option exercise price and related tax withholding. She also holds 1,837 shares indirectly through the issuer’s 401(k) plan trustee.

Insider Trade Summary

Net Seller: 22,000 shares ($2,075,399)

Net Sell 4 txns

Insider Daniels Jennifer

Role CLO and Secretary

Sold 22,000 shs ($2.08M)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	22,000	$0.00	--
Exercise	Common Stock	22,000	$72.29	$1.59M
Sale	Common Stock	22,000	$94.3363	$2.08M
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 0 shares (Direct); Common Stock — 98,406 shares (Direct); Common Stock — 1,837 shares (Indirect, By Issuer's 401(k) Plan Trustee)

Footnotes (1)

1. Exercise of stock options awarded under the issuer's incentive compensation plan. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.32 to $94.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Daniels Jennifer

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CLO and Secretary

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/04/2026		M(1)		22,000	A	$72.29	98,406	D
Common Stock	02/04/2026		S(2)		22,000	D	$94.3363(3)	76,406	D
Common Stock								1,837	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$72.29	02/04/2026		M(1)			22,000	(4)	09/12/2027	Common Stock	22,000	$0.0000	0.0000	D

Explanation of Responses:

1. Exercise of stock options awarded under the issuer's incentive compensation plan.

2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.

3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.32 to $94.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Colgate-Palmolive (CL) CLO Jennifer Daniels report?

Jennifer Daniels reported exercising stock options for 22,000 Colgate-Palmolive shares and then selling 22,000 shares the same day. The activity reflects routine use of equity compensation rather than a new company-level business development.

At what prices did Jennifer Daniels exercise and sell Colgate-Palmolive (CL) shares?

She exercised stock options at an exercise price of $72.29 per share and sold 22,000 common shares at a weighted average price of $94.3363. The sale price reflected multiple trades between $94.32 and $94.42 per share, according to the disclosure footnote.

How many Colgate-Palmolive (CL) shares does Jennifer Daniels hold after this Form 4?

After the reported transactions, Jennifer Daniels directly owns 76,406 Colgate-Palmolive common shares. She also has an additional 1,837 shares held indirectly through the issuer’s 401(k) plan trustee, as disclosed in the filing’s holdings table.

Why were some proceeds from Jennifer Daniels’ Colgate-Palmolive (CL) share sale delivered to the company?

A filing footnote explains that a portion of the sale proceeds was delivered to Colgate-Palmolive to pay the exercise price of the stock options and to satisfy related tax withholding obligations arising from the option exercise under the company’s incentive compensation plan.

What happened to Jennifer Daniels’ Colgate-Palmolive (CL) stock options in this transaction?

She exercised an option covering 22,000 shares of Colgate-Palmolive common stock at $72.29 per share, reducing her outstanding derivative position to zero. The option had become exercisable in one-third increments starting one year after its September 12, 2019 grant date.

Is Jennifer Daniels’ Colgate-Palmolive (CL) share sale a single trade or multiple trades?

The 22,000-share sale is reported with a single weighted average price of $94.3363 per share. A footnote states the shares were sold in multiple transactions at prices ranging from $94.32 to $94.42, and further detail is available on request.